AYTU vs EXAS · rev $66.4M vs rev $2.76B
Aytu BioScience Inc (AYTU) versus EXACT Sciences Corporation (EXAS) — a side-by-side from cached financials, not a winner call.
Aytu BioScience Inc (AYTU) is a drug manufacturers - specialty & generic company listed on US.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Latest reported AYTU revenue for 2025-06-30 was $66.4M. Net income was -$13.6M. AYTU currently screens at market cap $24.1M.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
AYTU currently screens at market cap $24.1M. EXAS currently screens at market cap $20.03B.
Not investment advice. Open the AYTU and EXAS stock pages for the full models.
Not investment advice.